企業プロフィール

Lyra Therapeutics 株価・ニュース・カタリスト

ティッカー:: LYRA
取引所:: NASDAQ
セクター:: Biopharma
所在地:: United States

株価パフォーマンス

0.01 USD (+2400.00%)

終値

最終更新: 2026年8月21日

—

時価総額

株価変動の要因

As of Aug 21, 2026, LYRA closed up 2400.0% at $0.0100. No new same-company headline was identified in the current news window.

企業概要

事業概要

Lyra Therapeutics is an otolaryngology company focused on chronic rhinosinusitis and upper-airway disease. Its platform uses localized delivery to treat difficult ENT conditions.

所在地とセクター分類

Headquartered in the United States and listed on NASDAQ, Lyra sits in specialty biotechnology.

ビジネスモデルの特徴

The company depends on clinical validation, delivery technology, and the ability to build a niche ENT franchise.

バイオ業界での位置付け

Lyra is a niche ENT catalyst name whose stock is driven by clinical and regulatory progress.

今後のカタリスト

Lyra’s catalysts are its GI-surgery and reflux platform, along with any commercial update that shows the device base is still growing. The story is about procedure adoption more than binary events.